TY - JOUR
T1 - Frailty among older adults with acute myocardial infarction and outcomes from percutaneous coronary interventions
AU - Damluji, Abdulla A.
AU - Huang, Jin
AU - Bandeen-Roche, Karen
AU - Forman, Daniel E.
AU - Gerstenblith, Gary
AU - Moscucci, Mauro
AU - Resar, Jon R.
AU - Varadhan, Ravi
AU - Walston, Jeremy D.
AU - Segal, Jodi B.
N1 - Funding Information:
Dr Damluji receives research funding from the Pepper Scholars Program of the Johns Hopkins University Claude D. Pepper Older Americans Independence Center (OAIC) funded by the National Institute on Aging (NIA) P30-AG021334. This study was also funded in part by a research grant from the Jane and Stanley F. Rodbell family in support of Geriatric Cardiology research at Sinai Hospital of Baltimore. Drs Bandeen-Roche and Walston are co-principal investigators of the OAIC; Drs Bandeen-Roche, Walston, and Gerstenblith are supported by funding from NIA P30-AG021334. Dr Segal is supported by funding from NIA 5K24-AG049036.
Publisher Copyright:
© 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2019/9/3
Y1 - 2019/9/3
N2 - Background-—Frailty is a predictor of adverse outcomes after acute myocardial infarction (AMI). Methods and Results-—We estimated the prevalence of frailty among adults age ≥75 years admitted with AMI and examined the relationship between frailty, interventions, and mortality. We used the Premier Healthcare Database to identify older adults with primary diagnoses of AMI. We classified individuals as frail or not using the validated Claims-based Frailty Index. We described patients’ characteristics and receipt of percutaneous coronary intervention stratified by frailty status. The primary outcome was hospital mortality. From 2000 to 2016, we identified 469 390 encounters for older patients admitted with AMI. The median age was 82 years, 53% were women, and 75% were white. The prevalence of frailty was 19%. Frail patients were less likely to receive percutaneous coronary intervention than nonfrail (15% versus 33%, P<0.001) and much less likely to receive coronary artery bypass surgery (1% versus 9%, P<0.001). There were far fewer interventions in individuals over age 85 years. Frailty was associated with higher mortality during AMI admission (unadjusted odds ratio [OR] 1.43, CI 1.39–1.46). While there was a differential benefit of the interventions because of frailty, frail patients had reduced hospital mortality with percutaneous coronary intervention (frail: OR 0.59, CI 0.55–0.63; nonfrail: OR 0.49, CI 0.47–0.50, P for interaction <0.001) and with coronary artery bypass surgery (frail: OR 0.77, CI 0.65–0.93; nonfrail: OR 0.74, CI 0.71–0.77, P for interaction <0.001) relative to no intervention. Conclusions-—In the United States, frailty is common among older patients admitted with AMI. While these vulnerable patients are at an increased risk for mortality, judicial use of revascularization with percutaneous coronary intervention in frail older patients still confers immediate survival benefit.
AB - Background-—Frailty is a predictor of adverse outcomes after acute myocardial infarction (AMI). Methods and Results-—We estimated the prevalence of frailty among adults age ≥75 years admitted with AMI and examined the relationship between frailty, interventions, and mortality. We used the Premier Healthcare Database to identify older adults with primary diagnoses of AMI. We classified individuals as frail or not using the validated Claims-based Frailty Index. We described patients’ characteristics and receipt of percutaneous coronary intervention stratified by frailty status. The primary outcome was hospital mortality. From 2000 to 2016, we identified 469 390 encounters for older patients admitted with AMI. The median age was 82 years, 53% were women, and 75% were white. The prevalence of frailty was 19%. Frail patients were less likely to receive percutaneous coronary intervention than nonfrail (15% versus 33%, P<0.001) and much less likely to receive coronary artery bypass surgery (1% versus 9%, P<0.001). There were far fewer interventions in individuals over age 85 years. Frailty was associated with higher mortality during AMI admission (unadjusted odds ratio [OR] 1.43, CI 1.39–1.46). While there was a differential benefit of the interventions because of frailty, frail patients had reduced hospital mortality with percutaneous coronary intervention (frail: OR 0.59, CI 0.55–0.63; nonfrail: OR 0.49, CI 0.47–0.50, P for interaction <0.001) and with coronary artery bypass surgery (frail: OR 0.77, CI 0.65–0.93; nonfrail: OR 0.74, CI 0.71–0.77, P for interaction <0.001) relative to no intervention. Conclusions-—In the United States, frailty is common among older patients admitted with AMI. While these vulnerable patients are at an increased risk for mortality, judicial use of revascularization with percutaneous coronary intervention in frail older patients still confers immediate survival benefit.
KW - Administrative claims
KW - Cardiovascular disease
KW - Elderly
KW - Frailty
KW - Myocardial infarction
UR - http://www.scopus.com/inward/record.url?scp=85071746976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071746976&partnerID=8YFLogxK
U2 - 10.1161/JAHA.119.013686
DO - 10.1161/JAHA.119.013686
M3 - Article
C2 - 31475601
AN - SCOPUS:85071746976
SN - 2047-9980
VL - 8
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 17
M1 - e013686
ER -